CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Go back to CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
(NASDAQ: CRSP) Delayed: 54.36 +0.27 (0.50%)
Previous Close $54.09    52 Week High $18.88 
Open $54.85    52 Week Low $13.75 
Day High $56.08    P/E N/A 
Day Low $54.08    EPS $0.00 
Volume 1,128,783